Qube Research & Technologies (QRT)
SLN

Qube Research & Technologies (QRT)’s Silence Therapeutics SLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$551K Buy
104,555
+69,593
+199% +$383K ﹤0.01% 2707
2025
Q4 		$213K Buy
+34,962
New +$224K ﹤0.01% 3044
2025
Q2 		– Sell
-18,913
Closed -$53.3K – 3932
2025
Q1 		$53.3K Sell
18,913
-35,833
-65% -$175K ﹤0.01% 3112
2024
Q4 		$377K Buy
54,746
+35,550
+185% +$459K ﹤0.01% 2611
2024
Q3 		$349K Buy
+19,196
New +$357K ﹤0.01% 2384
2024
Q2 		– Sell
-3,942
Closed -$85.1K – 4635
2024
Q1 		$85.1K Buy
3,942
+3,764
+2,115% +$81.8K ﹤0.01% 3361
2023
Q4 		$3.09K Hold
178
– – ﹤0.01% 3778
2023
Q3 		$1.75K Buy
+178
New +$1.31K ﹤0.01% 3590

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SLN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Silence Therapeutics (SLN) stake by 199% in Q1 2026, buying an estimated $383K and bringing the position to 104,555 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Qube Research & Technologies (QRT) first reported a position in SLN in Q3 2023 and has held it in 8 quarters since. 56 funds tracked by Wall St. Rank hold SLN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 104,555 shares of Silence Therapeutics worth $551K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 69,593 Silence Therapeutics shares in Q1 2026, an estimated $383K.
  • Silence Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2707 holding.
  • Qube Research & Technologies (QRT) first reported a position in Silence Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • 56 funds tracked by Wall St. Rank held Silence Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.